Authors:
GRIESSHAMMER M
ARNOLD R
BANGERTER M
HAFNER M
HEINZE B
HERTENSTEIN B
HEIMPEL H
BUNJES D
Citation: M. Griesshammer et al., CHRONIC MYELOID-LEUKEMIA IN ACCELERATED PHASE - TREATMENT RESULTS WITH CONVENTIONAL CHEMOTHERAPY AND ALLOGENEIC BONE-MARROW TRANSPLANTATIONIN 96 PATIENTS, European journal of haematology, 61(1), 1998, pp. 7-13
Authors:
KRATZER W
BLUM P
MASON R
SCHMITZ M
BECKH K
ADLER G
NOVAK P
HEIMPEL H
Citation: W. Kratzer et al., ALCOHOL-ASSOCIATED DISEASES IN INTERNAL-M EDICINE - A SCREENING STUDYON 1494 MEDICAL EMERGENCY PATIENTS, Leber, Magen, Darm, 28(3), 1998, pp. 115-121
Authors:
SANDHERR M
HERTENSTEIN B
BUNJES D
STEFANIC M
HEIMPEL H
ARNOLD R
Citation: M. Sandherr et al., ACUTE GRAFT-VERSUS-HOST DISEASE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION - A SINGLE-CENTER ANALYSIS ON RISK-FACTORS AND INFLUENCE ON MORBIDITY AND MORTALITY, Bone marrow transplantation, 21, 1998, pp. 394-394
Authors:
SCHREZENMEIER H
GRIESSHAMMER M
HORNKOHL A
NICHOL JL
HECHT T
HEIMPEL H
KUBANEK B
RAGHAVACHAR A
Citation: H. Schrezenmeier et al., THROMBOPOIETIN SERUM LEVELS IN PATIENTS WITH APLASTIC-ANEMIA - CORRELATION WITH PLATELET COUNT AND PERSISTENT ELEVATION IN REMISSION, British Journal of Haematology, 100(3), 1998, pp. 571-576
Authors:
GALE RP
HEHLMANN R
ZHANG MJ
HASFORD J
GOLDMAN JM
HEIMPEL H
HOCHHAUS A
KLEIN JP
KOLB HJ
MCGLAVE PB
PASSWEG JR
ROWLINGS PA
SOBOCINSKI KA
HOROWITZ MM
Citation: Rp. Gale et al., SURVIVAL WITH BONE-MARROW TRANSPLANTATION VERSUS HYDROXYUREA OR INTERFERON FOR CHRONIC MYELOGENOUS LEUKEMIA, Blood, 91(5), 1998, pp. 1810-1819
Authors:
DELANNOY A
KLUINNELEMANS JC
LOUWAGIE A
STRYCKMANNS P
SUCIU S
HEHLMANN R
HEIMPEL H
HASFORD J
ZUFFA E
BACCARANI M
TURA S
OHNISHI K
OHNO R
ALLAN N
SHEPHERD P
BROUSTET A
ALISON R
CLARKE M
DUONG H
GRAY R
GREAVES E
PETO R
RICHARDS S
SINCLAIR D
WHEATLEY K
Citation: A. Delannoy et al., INTERFERON-ALFA VERSUS CHEMOTHERAPY FOR CHRONIC MYELOID-LEUKEMIA - A METAANALYSIS OF 7 RANDOMIZED TRIALS, Journal of the National Cancer Institute, 89(21), 1997, pp. 1616-1620
Authors:
GRIESSHAMMER M
HEINZE B
BANGERTER M
HEIMPEL H
FLIEDNER TM
Citation: M. Griesshammer et al., KARYOTYPE ABNORMALITIES AND THEIR CLINICAL-SIGNIFICANCE IN BLAST CRISIS OF CHRONIC MYELOID-LEUKEMIA, Journal of molecular medicine, 75(11-12), 1997, pp. 836-838
Authors:
BANGERTER M
HERRMANN F
GRIESSHAMMER M
GRUSS HJ
HAFNER M
HEIMPEL H
BINDER T
Citation: M. Bangerter et al., THE ABUNDANT PRESENCE OF SODERSTROM BODIES IN CYTOLOGY SMEARS OF FINE-NEEDLE ASPIRATES CONTRIBUTES TO DISTINGUISHING HIGH-GRADE NON-HODGKINS-LYMPHOMA FROM CARCINOMA AND SARCOMA, Annals of hematology, 74(4), 1997, pp. 175-178
Authors:
BANGERTER M
MOOG F
GRIESSHAMMER M
MERKLE E
HAFNER M
ELLENRIEDER V
RESKE SN
HEIMPEL H
Citation: M. Bangerter et al., USEFULNESS OF FDG-PET IN DIAGNOSING PRIMARY LYMPHOMA OF THE LIVER, International journal of hematology, 66(4), 1997, pp. 517-520
Citation: H. Heimpel, THE PRESENT STATE OF PATHOPHYSIOLOGY AND THERAPEUTIC TRIALS IN POLYCYTHEMIA-VERA (VOL 65, PG 157, 1996), International journal of hematology, 65(2), 1997, pp. 191-191
Authors:
HEHLMANN R
ANSARI H
HASFORD J
HEIMPEL H
HOSSFELD DK
KOLB HJ
LOFFLER H
PRALLE H
QUEISSER W
REITER A
HOCHHAUS A
Citation: R. Hehlmann et al., COMPARATIVE-ANALYSIS OF THE IMPACT OF RISK PROFILE AND OF DRUG-THERAPY ON SURVIVAL IN CML USING SOKAL-INDEX AND A NEW SCORE, British Journal of Haematology, 97(1), 1997, pp. 76-85
Authors:
REITER A
SKLADNY H
HOCHHAUS A
SEIFARTH W
HEIMPEL H
BARTRAM CR
CROSS NCP
HEHLMANN R
Citation: A. Reiter et al., MOLECULAR RESPONSE OF CML PATIENTS TREATED WITH INTERFERON-ALPHA MONITORED BY QUANTITATIVE SOUTHERN BLOT ANALYSIS, British Journal of Haematology, 97(1), 1997, pp. 86-93
Authors:
FRICKHOFEN N
MULLER E
SANDHERR M
BINDER T
BANGERTER M
WIEST C
ENZ M
HEIMPEL H
Citation: N. Frickhofen et al., REARRANGED IG HEAVY-CHAIN DNA IS DETECTABLE IN CELL-FREE BLOOD-SAMPLES OF PATIENTS WITH B-CELL NEOPLASIA, Blood, 90(12), 1997, pp. 4953-4960
Authors:
GERHARTZ HH
SCHWENKE H
BAZARBASHI S
THIEL E
BLAU W
HUHN D
HEIMPEL H
BROWN P
SCHLIEMOK G
ILLIGER HJ
WALTHER J
WILMANNS W
CHARISSE G
FARBER L
HAUS U
Citation: Hh. Gerhartz et al., RANDOMIZED COMPARISON OF COPP ABVD VS. DOSE-ESCALATED AND TIME-ESCALATED COPP/ABVD WITH GM-CSF SUPPORT FOR ADVANCED HODGKINS-DISEASE/, Blood, 90(10), 1997, pp. 1731-1731
Authors:
HOCHHAUS A
HEHLMANN R
BARTRAM CR
HEIMPEL H
REITER A
BERGER U
ANSARI H
SKLADNY H
HEINZE B
HOSSFELD DK
Citation: A. Hochhaus et al., RANDOMIZED COMPARISON OF INTERFERON-ALPHA VS CHEMOTHERAPY IN PATIENTSWITH PHILADELPHIA-NEGATIVE CHRONIC MYELOGENOUS LEUKEMIA (CML), Blood, 90(10), 1997, pp. 2298-2298
Authors:
RAGHAVACHAR A
GANSER A
FREUND M
HEIMPEL H
HERRMANN F
SCHREZENMEIER H
Citation: A. Raghavachar et al., LONG-TERM INTERLEUKIN-3 AND INTENSIVE IMMUNOSUPPRESSION IN THE TREATMENT OF APLASTIC-ANEMIA, Cytokines and molecular therapy, 2(4), 1996, pp. 215-223
Citation: R. Hehlmann et H. Heimpel, CURRENT ASPECTS OF DRUG-THERAPY IN PHILADELPHIA-POSITIVE CML - CORRELATION OF TUMOR BURDEN WITH SURVIVAL, Leukemia & lymphoma, 22, 1996, pp. 161-167
Authors:
GRIESSHAMMER M
HEINZE B
HELLMANN A
POPP C
ANGER B
HEIL G
BANGERTER M
HEIMPEL H
Citation: M. Griesshammer et al., CHRONIC MYELOGENOUS LEUKEMIA IN BLAST CRISIS - RETROSPECTIVE ANALYSISOF PROGNOSTIC FACTORS IN 90 PATIENTS, Annals of hematology, 73(5), 1996, pp. 225-230
Citation: B. Hertenstein et al., ALLOGENIC BONE-MARROW TRANSPLANTATION OF CHEMOTHERAPY FOR PATIENTS WITH ACUTE MYELOID-LEUKEMIA IN FIRST COMPLETE REMISSION - A DECISION-ANALYSIS APPROACH, Annals of hematology, 72(4), 1996, pp. 223-230
Authors:
GLATZ S
KOTZERKE J
MOOG F
SANDHERR M
HEIMPEL H
RESKE SN
Citation: S. Glatz et al., SIMULATION OF A MEDIASTINAL NON-HODGKIN-L YMPHOMA RECURRENCE BY DIFFUSE THYMUS HYPERPLASIA IN F-18 FDG-PET, RoFo. Fortschritte auf dem Gebiete der Rontgenstrahlen und der neuenbildgebenden Verfahren, 165(3), 1996, pp. 309-310
Citation: H. Heimpel, THE PRESENT STATE OF PATHOPHYSIOLOGY AND THERAPEUTIC TRIALS IN POLYCYTHEMIA-VERA, International journal of hematology, 64(3-4), 1996, pp. 153-165